Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients

NCT ID: NCT06187701

Last Updated: 2025-04-01

Basic Information

• Recruitment Status: NOT_YET_RECRUITING
• Clinical Phase: NA
• Total Enrollment: 10 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2026-03-31
• Study Completion Date: 2027-12-31

Brief Summary

Drama Therapy involves of the use of theatrical techniques (such as script development, acting exercises, improvisation, etc.) to help treat patients' mental illness and improve their functioning and overall sense of wellbeing.

This study will evaluate the effectiveness of a specific version of drama therapy for the treatment of patients suffering from both mental illness (such as depression, bipolar disorder, schizophrenia, etc.) and one or more substance use disorders. The study will also assess participants feelings and thoughts about the drama therapy intervention (such as whether or not they enjoyed it and if/how they found it helpful).

The drama therapy intervention will consist of one group drama therapy session per week, for a total of twelve weeks (i.e., total twelve sessions) followed by a single performance (with composition of the audience determined by unanimous agreement of the participants) of the dramatic work (script) produced by the participants during the course of the drama therapy intervention.

Conditions

Mental Health Issue; Substance Use Disorders

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Co-Active Therapeutic Theatre (Co-ATT)

Drama therapy will be used to treat participants with co-occurring primary psychiatric and substance use disorders

Group Type: EXPERIMENTAL

Co-Active Therapeutic Theatre (Co-ATT)

Intervention Type: BEHAVIORAL

There will be one group drama therapy session per week, for a total of twelve weeks (i.e., total twelve sessions) followed by a single performance (with composition of the audience determined by unanimous agreement of the participants) of the dramatic work (script) produced by the participants during the course of the drama therapy intervention.

Interventions

Co-Active Therapeutic Theatre (Co-ATT)

There will be one group drama therapy session per week, for a total of twelve weeks (i.e., total twelve sessions) followed by a single performance (with composition of the audience determined by unanimous agreement of the participants) of the dramatic work (script) produced by the participants during the course of the drama therapy intervention.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• Diagnosed with at least one primary psychiatric disorder, and
• Diagnosed with at least one substance use disorder
• Both disorders active (i.e., meeting DSM-V criteria for each disorder (i.e., with ongoing psychiatric symptoms and ongoing substance use)
• Enrolled in the Addiction Psychiatry Treatment Program (APTP) at Boston Medical Center (i.e., scheduled for follow-up appointments with therapist and/or psychiatrist in APTP).
• Currently taking medications and those not currently taking medications

Exclusion Criteria

• Incarcerated persons
• Pregnant women
• Inability to understand and/or sign informed consent form

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Boston Medical Center

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

William-Bernard Reid-Varley, MD MPH

Role: PRINCIPAL_INVESTIGATOR

Boston Medical Center, Psychiatry Department

Locations

Boston Medical Center

Boston, Massachusetts, United States

Countries

United States

Central Contacts

William-Bernard Reid-Varley, MD MPH

Role: CONTACT

William-Bernard.Reid-Varley@bmc.org

617-638-8014

Facility Contacts

William-Bernard Reid-Varley, MD MPH

Role: primary

William-Bernard.Reid-Varley@bmc.org

617-638-8014

Other Identifiers

H-43656

Identifier Type: -

Identifier Source: org_study_id